REAGENT or RESOURCE | SOURCE | IDENTIFIER |
---|---|---|
Bacterial and virus strains | ||
Recombinant SARS-CoV-2 | This study | N/A |
Recombinant SARS-CoV-2 (nsp14-P203L) | This study | N/A |
Escherichia coli DH5-a | New England Biolabs | Cat#C2987 |
Chemicals, peptides, and recombinant proteins | ||
TransIT-LT1 Transfection Reagent | Takara | Cat# MIR2300 |
Fetal bovine serum | Gibco | Cat# 42Q7361K |
Penicillin-streptomycin | Nacalai | Cat# 09367-34 |
DMEM (high glucose) | Nacalai Tesque | Cat# 08459-64 |
DMEM high glucose powder | Sigma | Cat# D5648 |
HEPES(1M) | Gibco | Cat# 15630080 |
Amphotericin B solution (250 ug/mL) | Sigma | Cat# A2942 |
Gentamicin Sulfate Solution (50mg/ml) | nacalai | Cat# 11980-14 |
7.5% NaHCO3 | Sigma | Cat# S8761-100ML |
SeaPlaque Agarose | Lonza | Cat# 50100 |
SeaKem Agarose | Lonza | Cat# 50074 |
G418 | Nacalai Tesque | Cat# 09380-44 |
Critical commercial assays | ||
QIAamp viral RNA mini kit | Qiagen | Cat# 52906 |
PrimeSTAR GXL DNA polymerase | Takara | Cat# R050A |
ProtoScript II Reverse Transcriptase | New England Biolabs | Cat# M0368S |
NEBNext® Ultra™ II Non-Directional RNA Second Strand Synthesis Module |
New England Biolabs | Cat# E6111S/L |
SureSelectXT HS and XT Low input enzymatic fragmentation kit | Agilent | Cat# 5191-4080 |
NovaSeq 6000 S4 Reagent Kit v1.5 (200 cycles) | Illumina | Cat# 20028313 |
PrimeScript 1st strand cDNA Synthesis Kit | Takara | Cat# 6110A |
Custom probe | Agilent | https://www.agilent.com/cs/library/applications/application-sars-cov-2-sequencing-5994-4538en-agilent.pdf |
Deposited data | ||
Viral genome sequencing data by RNA-seq | DDBJ Sequence Read Archive | Accession number: DRR411740 - DRR411753 |
Experimental models: Cell lines | ||
Human: HEK293-hACE2/hTMPRSS2 cells | This study | N/A |
African green monkey (Chlorocebus sabaeus): VeroE6/TMPRSS2 cells | JCRB Cell Bank | JCRB1819 |
Oligonucleotides | ||
Linker/F1-F: CTATATAAGCAGAGCTCGTTT AGTGAACCGTattaaaggtttataccttcccaggtaac |
Torii et al.26 | N/A |
F1/F2-R: cagattcaacttgcatgg cattgttagtagccttatttaaggctcctgc |
Torii et al.26 | N/A |
F1/F2-F: gcaggagccttaaataaggctacta acaatgccatgcaagttgaatctg |
Torii et al.26 | N/A |
F2/F3-R: ggtaggattttccactacttcttcaga gactggttttagatcttcgcaggc |
Torii et al.26 | N/A |
F2/F3-F: gcctgcgaagatctaaaaccagtctct gaagaagtagtggaaaatcctacc |
Torii et al.26 | N/A |
F3/F4-R: ggtgcacagcgca gcttcttcaaaagtactaaagg |
Torii et al.26 | N/A |
F3/F4-F: caccactaattcaacctattggtgctttg gacatatcagcatctatagtagctggtgg |
Torii et al.26 | N/A |
F4/F5-R: gtttaaaaacgattgtgcatcagctgactg | Torii et al.26 | N/A |
F4/F5-F: cacagtctgtaccgtctgcggtatgtgga aaggttatggctgtagttgtgatc |
Torii et al.26 | N/A |
F5/F6-R: gcggtgtgtacatagcctcataaaactca ggttcccaataccttgaagtg |
Torii et al.26 | N/A |
F5/F6-F: cacttcaaggtattgggaacctgagttttatg aggctatgtacacaccgc |
Torii et al.26 | N/A |
F6/F7-R: catacaaactgccaccatcacaaccagg caagttaaggttagatagcactctag |
Torii et al.26 | N/A |
F6/F7-F: ctagagtgctatctaaccttaacttgcctggt tgtgatggtggcagtttgtatg |
Torii et al.26 | N/A |
F7/F8-R: ctagagactagtggcaataaaacaagaaaa acaaacattgttcgtttagttgttaac |
Torii et al.26 | N/A |
F7/F8-F: gttaacaactaaacgaacaatgtttgtttttcttg ttttattgccactagtctctag |
Torii et al.26 | N/A |
F8/F9-R: gcagcaggatccacaagaacaacagccctt gagacaactacagcaactgg |
Torii et al.26 | N/A |
F8/F9-F: ccagttgctgtagttgtctcaagggctgttgtt cttgtggatcctgctgc |
Torii et al.26 | N/A |
F9/Linker-R: GGAGATGCCATGCCGACCC tttttttttttttttttttttttttgtcattctcctaag |
Torii et al.26 | N/A |
F9/Linker-F: cttaggagaatgacaaaaaaaaaaaaaaa aaaaaaaaaaGGGTCGGCATGGCATCTCC |
Torii et al.26 | N/A |
Linker/F1-R: gttacctgggaaggtataaacctttaatAC GGTTCACTAAACGAGCTCTGCTTATATAG |
Torii et al.26 | N/A |
Recombinant DNA | ||
Plasmid: pCSII-sars-cov-2 F1 | Torii et al.26 | N/A |
Plasmid: pCSII-sars-cov-2 F2 | Torii et al.26 | N/A |
Plasmid: pCSII-sars-cov-2 F3 | Torii et al.26 | N/A |
Plasmid: pCSII-sars-cov-2 F4 | Torii et al.26 | N/A |
Plasmid: pcDNA3.1.-sars-cov-2 F5 | Torii et al.26 | N/A |
Plasmid: pcDNA3.1.-sars-cov-2 F6 | Torii et al.26 | N/A |
Plasmid: pcDNA3.1.-sars-cov-2 F6 (nsp14-P203L) | This study | N/A |
Plasmid: pCSII-sars-cov-2 F7 | Torii et al.26 | N/A |
Plasmid: pCSII-sars-cov-2 F8 | Torii et al.26 | N/A |
Plasmid: pCSII-sars-cov-2 F9 | Torii et al.26 | N/A |
Plasmid: pMW118 CoV2-CMVlinker | Torii et al.26 | N/A |
Software and algorithms | ||
MAFFT version v7.453 | Katoh and Standley27 | https://mafft.cbrc.jp/alignment/software |
WebLogo 3 | Crooks et al.14 | https://weblogo.threeplusone.com |
ProtTest3 version 3.4.2 | Darriba et al.28 | https://github.com/ddarriba/prottest3 |
RAxML-NG version 1.0.0 | Kozlov et al.29 | https://github.com/amkozlov/raxml-ng |
CD-HIT-EST version 4.8.1 | Li et al.30 | https://sites.google.com/view/cd-hit |
ModelTest-NG | Darriba et al.31 | https://github.com/ddarriba/modeltest |
MEGA X | Kumar et al.32 | https://www.megasoftware.net |
TranslatorX | Abascal et al.33 | http://translatorx.co.uk |
Datamonkey software | Weaver et al.34 | https://www.datamonkey.org |
cutadapt version 3.2 | Martin35 | https://cutadapt.readthedocs.io/en/v3.2/ |
BWA version 0.7,17-r1188 | Li and Durbin36 | http://bio-bwa.sourceforge.net |
MuTect2 in GATK suite version 4.2 | McKenna et al.37 | https://github.com/broadinstitute/gatk/releases |
PyMOL molecular graphics system v2.4.0 | The PyMOL Molecular Graphics System, Version 2.0 Schrödinger, LLC | https://pymol.org/ |
BeAtMuSiC program version 1.0 | Dehouck et al.38 | http://babylone.3bio.ulb.ac.be/beatmusic/ |
GraphPad Prism software version 9.4.0 | GraphPad Software | https://www.graphpad.com/scientific-software/prism/ |
FigTree v1.4.4 | http://tree.bio.ed.ac.uk/software/figtree/ | http://tree.bio.ed.ac.uk/software/figtree/ |
R v4.2.1 | The R Foundation | https://www.r-project.org/ |
Python v3.7 | Python Software Foundation | https://www.python.org |
Other | ||
GISAID EpiCoV database | Shu et al.12 | https://epicov.org/epi3/epi_set/230110sz |